IBDEI0SQ ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12800,0)
 ;;=N42.89^^80^787^33
 ;;^UTILITY(U,$J,358.3,12800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12800,1,3,0)
 ;;=3^Prostate Disorders NEC
 ;;^UTILITY(U,$J,358.3,12800,1,4,0)
 ;;=4^N42.89
 ;;^UTILITY(U,$J,358.3,12800,2)
 ;;=^270425
 ;;^UTILITY(U,$J,358.3,12801,0)
 ;;=N41.9^^80^787^23
 ;;^UTILITY(U,$J,358.3,12801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12801,1,3,0)
 ;;=3^Inflammatory Disease of Prostate,Unspec
 ;;^UTILITY(U,$J,358.3,12801,1,4,0)
 ;;=4^N41.9
 ;;^UTILITY(U,$J,358.3,12801,2)
 ;;=^5015694
 ;;^UTILITY(U,$J,358.3,12802,0)
 ;;=N43.3^^80^787^22
 ;;^UTILITY(U,$J,358.3,12802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12802,1,3,0)
 ;;=3^Hydrocele,Unspec
 ;;^UTILITY(U,$J,358.3,12802,1,4,0)
 ;;=4^N43.3
 ;;^UTILITY(U,$J,358.3,12802,2)
 ;;=^5015700
 ;;^UTILITY(U,$J,358.3,12803,0)
 ;;=N47.1^^80^787^32
 ;;^UTILITY(U,$J,358.3,12803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12803,1,3,0)
 ;;=3^Phimosis
 ;;^UTILITY(U,$J,358.3,12803,1,4,0)
 ;;=4^N47.1
 ;;^UTILITY(U,$J,358.3,12803,2)
 ;;=^93340
 ;;^UTILITY(U,$J,358.3,12804,0)
 ;;=N47.2^^80^787^31
 ;;^UTILITY(U,$J,358.3,12804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12804,1,3,0)
 ;;=3^Paraphimosis
 ;;^UTILITY(U,$J,358.3,12804,1,4,0)
 ;;=4^N47.2
 ;;^UTILITY(U,$J,358.3,12804,2)
 ;;=^90023
 ;;^UTILITY(U,$J,358.3,12805,0)
 ;;=N52.9^^80^787^16
 ;;^UTILITY(U,$J,358.3,12805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12805,1,3,0)
 ;;=3^Erectile Dysfunction,Unspec
 ;;^UTILITY(U,$J,358.3,12805,1,4,0)
 ;;=4^N52.9
 ;;^UTILITY(U,$J,358.3,12805,2)
 ;;=^5015763
 ;;^UTILITY(U,$J,358.3,12806,0)
 ;;=N52.8^^80^787^11
 ;;^UTILITY(U,$J,358.3,12806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12806,1,3,0)
 ;;=3^Erectile Dysfunction NEC
 ;;^UTILITY(U,$J,358.3,12806,1,4,0)
 ;;=4^N52.8
 ;;^UTILITY(U,$J,358.3,12806,2)
 ;;=^5015762
 ;;^UTILITY(U,$J,358.3,12807,0)
 ;;=N52.39^^80^787^15
 ;;^UTILITY(U,$J,358.3,12807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12807,1,3,0)
 ;;=3^Erectile Dysfunction,Post-Surgical NEC
 ;;^UTILITY(U,$J,358.3,12807,1,4,0)
 ;;=4^N52.39
 ;;^UTILITY(U,$J,358.3,12807,2)
 ;;=^5015761
 ;;^UTILITY(U,$J,358.3,12808,0)
 ;;=N52.34^^80^787^9
 ;;^UTILITY(U,$J,358.3,12808,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12808,1,3,0)
 ;;=3^Erectile Dysfunction Following Simple Prostatectomy
 ;;^UTILITY(U,$J,358.3,12808,1,4,0)
 ;;=4^N52.34
 ;;^UTILITY(U,$J,358.3,12808,2)
 ;;=^5015760
 ;;^UTILITY(U,$J,358.3,12809,0)
 ;;=N52.33^^80^787^10
 ;;^UTILITY(U,$J,358.3,12809,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12809,1,3,0)
 ;;=3^Erectile Dysfunction Following Urethral Surgery
 ;;^UTILITY(U,$J,358.3,12809,1,4,0)
 ;;=4^N52.33
 ;;^UTILITY(U,$J,358.3,12809,2)
 ;;=^5015759
 ;;^UTILITY(U,$J,358.3,12810,0)
 ;;=N52.32^^80^787^7
 ;;^UTILITY(U,$J,358.3,12810,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12810,1,3,0)
 ;;=3^Erectile Dysfunction Following Radical Cystectomy
 ;;^UTILITY(U,$J,358.3,12810,1,4,0)
 ;;=4^N52.32
 ;;^UTILITY(U,$J,358.3,12810,2)
 ;;=^5015758
 ;;^UTILITY(U,$J,358.3,12811,0)
 ;;=N52.31^^80^787^8
 ;;^UTILITY(U,$J,358.3,12811,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12811,1,3,0)
 ;;=3^Erectile Dysfunction Following Radical Prostatectomy
 ;;^UTILITY(U,$J,358.3,12811,1,4,0)
 ;;=4^N52.31
 ;;^UTILITY(U,$J,358.3,12811,2)
 ;;=^5015757
 ;;^UTILITY(U,$J,358.3,12812,0)
 ;;=N52.2^^80^787^14
 ;;^UTILITY(U,$J,358.3,12812,1,0)
 ;;=^358.31IA^4^2
